Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × dapagliflozin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Inflammation 1 Hyperinsulinism 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Heart Failure 1 Cardiotoxicity 1

Interventions

Carvedilol 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Trastuzumab 1 Specimen Handling 1 Secondary Prevention 1 Perindopril 1 Ogivri 1 Metoprolol 1 Exercise 1 Electronic Health Records 1 Echocardiography 1 Carnitine 1 Bisoprolol 1 Adrenergic beta-Antagonists 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting

Breast Neoplasms, Heart Failure, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡